NDA 211083 describes ERLOTINIB HYDROCHLORIDE, which is a drug marketed by
Accord Hlthcare,
Alembic,
Apotex,
Chartwell Rx,
Eugia Pharma,
Hetero Labs Ltd V,
MSN,
Natco Pharma Ltd,
Rising,
Shilpa,
Sun Pharm,
Teva Pharms Usa Inc, and
Zydus Pharms, and is included in thirteen NDAs. It is available from
twelve suppliers. Additional details are available on the
ERLOTINIB HYDROCHLORIDE profile page.
The generic ingredient in ERLOTINIB HYDROCHLORIDE is
erlotinib hydrochloride. There are twenty-five
drug master file entries for this compound. Thirteen
suppliers are listed for this compound. Additional details are available on the
erlotinib hydrochloride profile page.